ArticleCancers2023

Patients with Very High Risk of Cardiovascular Adverse Events during Carfilzomib Therapy: Prevention and Management of Events in a Single Center Experience.

Giulia Mingrone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.